On October 10th Children's Hospital Trust hosted an event entitled "The Next Big Idea" at the Four Seasons Hotel. Denisa Wagner was a featured speaker presenting her latest research findings on ‘Thrombosis and Stroke" as part of the Trust's Flashpoint Campaign. Timothy Springer, a member of the Trust Board, was an organizer of the event.
(l to r):
Harvey Lodish, Mark Puder, Marsha Moses, George Daley, Denisa Wagner, and Isaac Kohane. Photo courtesy of John Gillooly.
Harvey Lodish, a Boston Children's Hospital Trustee, concluded the presentations by highlighting the recent merger of the Immune Disease Institute with the hospital as the Program in Cellular and Molecular Medicine. He lauded the amazing research going on at BCH and noted that it ranks way above all other Children's Hospitals in the nation in ongoing research and support.
Founded in 1953, the Program in Molecular and Cellular Medicine and the Immune Disease Institute (PCMM/IDI) is a non-profit research institution in Boston, MA, recognized worldwide for its discoveries that increase the body's ability to fight disease and to heal. With the aim of increasing collaborations and scientific synergies, Immune Disease Institute and Children’s Hospital Boston have entered into an affiliation whereby IDI joins seven other interdisciplinary programs as the Program in Cellular and Molecular Medicine. PCMM/IDI is also academically affiliated with Harvard Medical School, and its investigators hold appointments in departments of the medical school.
The breakthroughs of PCMM/IDI scientists are greatly increasing our understanding of the influence of immune defense and inflammation on biomedical discovery, healthcare, and disease management. Visit About Us to learn more.
